河北医科大学学报
河北醫科大學學報
하북의과대학학보
JOURNAL OF HEBEI MEDICAL UNIVERSITY
2015年
4期
412-415
,共4页
乔木%张丽静%邱锐琴%韩艳艳%李宝琪%姚文秀
喬木%張麗靜%邱銳琴%韓豔豔%李寶琪%姚文秀
교목%장려정%구예금%한염염%리보기%요문수
呼吸窘迫综合征,新生儿%间歇正压通气%生物制剂
呼吸窘迫綜閤徵,新生兒%間歇正壓通氣%生物製劑
호흡군박종합정,신생인%간헐정압통기%생물제제
respiratory distress syndrome,newborn%intermittent positive-pressure ventilation%biological agents
目的:探讨应用气管插管-使用肺表面活性物质-拔管使用经鼻塞式气道正压通气(intubation surfactant-extubation,INSURE)策略的早产儿早期肠道内添加益生菌制剂金双歧的临床价值。方法将符合条件的给予 INSURE 策略治疗的患有呼吸窘迫综合征早产儿86例随机分为对照组42例和试验组44例,对照组给予常规治疗,试验组在此基础上给予口服双歧杆菌乳杆菌三联活菌片治疗,0.5 g/次,3次/d,对治疗效果进行统计学分析。结果与对照组相比,试验组喂养不耐受发生率低(χ2=4.693,P <0.05),达全胃肠喂养所需时间早(t =2.385,P <0.05),温盐水灌肠次数减少(t =2.925,P <0.05),更早恢复出生体质量(t =4.541,P <0.05),发生胆汁淤积比率降低(χ2=4.671,P <0.05)。2组坏死性小肠结肠炎发生率差异无统计学意义,试验组无益生菌相关性败血症发生。结论对 INSURE 策略治疗早产儿进行更为积极的保护性喂养策略,即早期微量喂养同时添加肠道益生菌,对胃肠功能恢复、促进生长发育、减少胆汁淤积并发症等方面效果良好,无明显不良反应,值得临床推广。
目的:探討應用氣管插管-使用肺錶麵活性物質-拔管使用經鼻塞式氣道正壓通氣(intubation surfactant-extubation,INSURE)策略的早產兒早期腸道內添加益生菌製劑金雙歧的臨床價值。方法將符閤條件的給予 INSURE 策略治療的患有呼吸窘迫綜閤徵早產兒86例隨機分為對照組42例和試驗組44例,對照組給予常規治療,試驗組在此基礎上給予口服雙歧桿菌乳桿菌三聯活菌片治療,0.5 g/次,3次/d,對治療效果進行統計學分析。結果與對照組相比,試驗組餵養不耐受髮生率低(χ2=4.693,P <0.05),達全胃腸餵養所需時間早(t =2.385,P <0.05),溫鹽水灌腸次數減少(t =2.925,P <0.05),更早恢複齣生體質量(t =4.541,P <0.05),髮生膽汁淤積比率降低(χ2=4.671,P <0.05)。2組壞死性小腸結腸炎髮生率差異無統計學意義,試驗組無益生菌相關性敗血癥髮生。結論對 INSURE 策略治療早產兒進行更為積極的保護性餵養策略,即早期微量餵養同時添加腸道益生菌,對胃腸功能恢複、促進生長髮育、減少膽汁淤積併髮癥等方麵效果良好,無明顯不良反應,值得臨床推廣。
목적:탐토응용기관삽관-사용폐표면활성물질-발관사용경비새식기도정압통기(intubation surfactant-extubation,INSURE)책략적조산인조기장도내첨가익생균제제금쌍기적림상개치。방법장부합조건적급여 INSURE 책략치료적환유호흡군박종합정조산인86례수궤분위대조조42례화시험조44례,대조조급여상규치료,시험조재차기출상급여구복쌍기간균유간균삼련활균편치료,0.5 g/차,3차/d,대치료효과진행통계학분석。결과여대조조상비,시험조위양불내수발생솔저(χ2=4.693,P <0.05),체전위장위양소수시간조(t =2.385,P <0.05),온염수관장차수감소(t =2.925,P <0.05),경조회복출생체질량(t =4.541,P <0.05),발생담즙어적비솔강저(χ2=4.671,P <0.05)。2조배사성소장결장염발생솔차이무통계학의의,시험조무익생균상관성패혈증발생。결론대 INSURE 책략치료조산인진행경위적겁적보호성위양책략,즉조기미량위양동시첨가장도익생균,대위장공능회복、촉진생장발육、감소담즙어적병발증등방면효과량호,무명현불량반응,치득림상추엄。
Objective To explore the clinical application value of early microecological treatment with golden bifid on the applying of intubation-surfactant-extubation(INSURE)for premature infants.Methods Eighty-six premature infants with respiratory distress syndrome (RDS)treated by applying INSURE were randomly divided into two groups.Patients of both groups were subjected to routine treatments.Besides,patients of the treatment group were given live combined Bifidobacterium and Lactobacillus tablets,0.5 g,3 times/day.Results There were significant differences in the incidence of feeding intolerance(χ2 =4.693,P <0.05),enough feeding time(t = 2.385,P < 0.05 ),the number of warm brine enema(t = 2.925,P < 0.05 ),birth mass recovery time(t =4.541,P <0.05),and incidence of cholestasis(χ2 =4.671,P < 0.05).But,there were no significant differences in the incidence of necrotizing enterocolitis.The probiotics was not related to the occurrence of sepsis.Conclusion The premature infants with RDS treated by INSURE strategy benefit the implementation of early microecological treatment over to the full amount feeding by gastrointestinal tract,better growth weight,reduce cholestasis occurrence,no side effect was found.It is worth clinical promotion.